GC Green Cross MS: "Export Approval for Rapid and Molecular Hantavirus Diagnostic Kits"
Holds approvals for seven infectious disease diagnostic products
Expands push into the global diagnostics market
GC Green Cross MS said on Nov. 18 that it had received export approval from the Ministry of Food and Drug Safety for its rapid and molecular diagnostic kits for hantavirus.
The company received export approval for its rapid hantavirus diagnostic kit on Oct. 30 and subsequently secured approval for its PCR-based molecular diagnostic kit on Nov. 12.
GC Green Cross MS's rapid and molecular diagnostic kits for hantavirus. GC Green Cross MS
View original imageGC Green Cross MS currently holds approvals for seven infectious disease diagnostic products: six for export, including four dengue diagnostic reagents, one chikungunya diagnostic reagent, and one mpox virus diagnostic reagent, and one malaria diagnostic reagent for the domestic market. With the addition of its rapid and molecular diagnostic kits for hantavirus, the company has expanded its portfolio.
Hot Picks Today
"Two Spend 500,000 Won in a Flash, Yet Wait Two Hours?" ... 'Dreamland' Shunned by Kids and Foreign Tourists
- The Era of Getting 200 Million Won After 30 Years Is Over... A Japanese Bank's "Perpetual Department Head" Who Just Clocked In Cries Out
- Spain Hit by Its Worst Tragedy... Lee Kangin, Moreno and Real Madrid Join Soccer World in Mourning
- They Said, “Make It Your Home for Life” - Then Suddenly Kicked 200 Passengers Off... What Happened to the Around-the-World Cruise?
- "130 Rice Bowls Sold Out in a Day"... 'Unfiltered Face' Adds 8 Million Won to Night Market Sales: China's Bungeunwoo
GC Green Cross MS plans to continue the research and development and commercialization of diagnostic products for major infectious diseases. A company official said, "We will continue to research, develop, and commercialize diagnostic products for major infectious diseases, and leverage our accumulated overseas sales network to expand the countries and product categories we serve, translating this into revenue growth for our global diagnostics business."
© The Asia Business Daily. All rights reserved. Unauthorized AI training and use prohibited.